IS7663A - Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum - Google Patents
Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumumInfo
- Publication number
- IS7663A IS7663A IS7663A IS7663A IS7663A IS 7663 A IS7663 A IS 7663A IS 7663 A IS7663 A IS 7663A IS 7663 A IS7663 A IS 7663A IS 7663 A IS7663 A IS 7663A
- Authority
- IS
- Iceland
- Prior art keywords
- embryonic stem
- human embryonic
- heart muscle
- cells
- stem cells
- Prior art date
Links
- 210000004413 cardiac myocyte Anatomy 0.000 title 1
- 210000001671 embryonic stem cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5061—Muscle cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39933002P | 2002-07-26 | 2002-07-26 | |
| PCT/US2003/023174 WO2004011603A2 (en) | 2002-07-26 | 2003-07-25 | Functional cardiomyocytes from human embryonic stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7663A true IS7663A (is) | 2005-01-25 |
Family
ID=31188569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7663A IS7663A (is) | 2002-07-26 | 2005-01-25 | Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7611852B2 (is) |
| EP (1) | EP1551991A4 (is) |
| JP (1) | JP2005533518A (is) |
| KR (1) | KR20050026008A (is) |
| CN (1) | CN1671860A (is) |
| AU (1) | AU2003252155B2 (is) |
| BR (1) | BR0312764A (is) |
| CA (1) | CA2493588C (is) |
| IL (1) | IL165943A0 (is) |
| IS (1) | IS7663A (is) |
| MX (1) | MXPA05000283A (is) |
| NO (1) | NO20051030L (is) |
| NZ (1) | NZ537245A (is) |
| WO (1) | WO2004011603A2 (is) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005500847A (ja) * | 2001-08-24 | 2005-01-13 | アドバンスド セル テクノロジー、インコーポレイテッド | 分化誘導薬の同定のためのスクリーニング検定及び細胞治療用の分化細胞の調製 |
| US8263375B2 (en) | 2002-12-20 | 2012-09-11 | Acea Biosciences | Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology |
| US7192752B2 (en) | 2002-12-20 | 2007-03-20 | Acea Biosciences | Real time electronic cell sensing systems and applications for cell-based assays |
| US10215748B2 (en) | 2002-12-20 | 2019-02-26 | Acea Biosciences, Inc. | Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways |
| US10539523B2 (en) | 2002-12-20 | 2020-01-21 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties |
| US10551371B2 (en) | 2003-11-10 | 2020-02-04 | Acea Biosciences, Inc. | System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function |
| US9612234B2 (en) | 2008-05-05 | 2017-04-04 | Acea Biosciences, Inc. | Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments |
| US11346797B2 (en) | 2002-12-20 | 2022-05-31 | Agilent Technologies, Inc. | System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties |
| AU2003901099A0 (en) * | 2003-03-11 | 2003-03-27 | Es Cell International Pte Ltd. | Methods of inducing differentiation of stem cells |
| EP1740945B1 (en) * | 2004-04-07 | 2018-09-19 | Ncardia AG | Non-invasive, in vitro functional tissue assay systems |
| ES2579954T3 (es) | 2004-05-11 | 2016-08-17 | Axiogenesis Ag | Ensayo para el descubrimiento de fármacos basado en células diferenciadas in vitro |
| US20050277124A1 (en) * | 2004-06-10 | 2005-12-15 | White Steven M | Cardiac conduction system cells and uses thereof |
| US20100150887A1 (en) * | 2007-01-25 | 2010-06-17 | Duff Henry J | Tissue Progenitor Cells That Overexpress ERG |
| US8153427B2 (en) * | 2007-03-15 | 2012-04-10 | California Stem Cell, Inc. | Cardiomyocytes and methods of producing and purifying cardiomyocytes |
| US8202720B2 (en) * | 2007-06-08 | 2012-06-19 | Mitsubishi Chemical Medience Corporation | Model cell chip, apparatus for evaluating drug effect using the model cell chip and method of evaluating drug effect |
| WO2009137440A1 (en) | 2008-05-05 | 2009-11-12 | Acea Biosciences, Inc. | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution |
| US8603817B2 (en) * | 2008-11-03 | 2013-12-10 | University Of Washington | Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling |
| EP2218772A1 (en) | 2009-02-09 | 2010-08-18 | Koninklijke Philips Electronics N.V. | Cardiomyocytes-containing device and method for manufacturing the same |
| WO2010094694A1 (en) * | 2009-02-23 | 2010-08-26 | F. Hoffmann-La Roche Ag | Assays to predict cardiotoxicity |
| CN104774804B (zh) * | 2010-06-13 | 2018-10-26 | 中国科学院生物物理研究所 | 由干细胞制备心肌细胞的方法和组合物及其用途 |
| WO2012017343A2 (en) * | 2010-08-05 | 2012-02-09 | Koninklijke Philips Electronics N.V. | Cardiomyocyte containing device, manufacturing method and measuring method |
| KR101364965B1 (ko) * | 2010-10-06 | 2014-02-18 | (주)차바이오앤디오스텍 | 인간 배아줄기세포 유래 심근세포의 배양 및 정제 방법 |
| BR112013009888A2 (pt) * | 2010-10-29 | 2021-07-20 | F. Hoffmann - La Roche Ag | método para determinar o risco de arritmia |
| US9155765B2 (en) | 2011-07-05 | 2015-10-13 | Baylor Research Institute | Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs) |
| CN103987854A (zh) | 2011-07-21 | 2014-08-13 | 小利兰·斯坦福大学托管委员会 | 来自患者的诱导性多能干细胞的心肌细胞及其使用方法 |
| CN104237308B (zh) * | 2013-06-09 | 2016-08-31 | 国家纳米科学中心 | 一种在体外筛选药物的方法 |
| US9983198B2 (en) * | 2015-03-19 | 2018-05-29 | Axion Biosystems, Inc. | Systems and methods for assessing data collected from an electrically active cell culture |
| US12066428B2 (en) | 2015-11-20 | 2024-08-20 | Agilent Technologies, Inc. | Cell-substrate impedance monitoring of cancer cells |
| US11674952B2 (en) | 2016-02-24 | 2023-06-13 | The Rockefeller University | Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof |
| EP3589299B1 (en) | 2017-03-03 | 2025-04-09 | Agilent Technologies, Inc. | METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES |
| USD941488S1 (en) | 2020-02-07 | 2022-01-18 | Agilent Technologies, Inc. | Instrument for analyzing biological cells |
| US20210301245A1 (en) | 2020-03-29 | 2021-09-30 | Agilent Technologies, Inc. | Systems and methods for electronically and optically monitoring biological samples |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4441327C1 (de) * | 1994-11-22 | 1995-11-09 | Inst Pflanzengenetik & Kultur | Embryonale Herzmuskelzellen, ihre Herstellung und ihre Verwendung |
| DE19727962A1 (de) * | 1997-07-02 | 1999-01-14 | Juergen Hescheler | Fluoreszierende Proteine als zelltypspezifische Reporter |
| DE19843234A1 (de) | 1998-09-09 | 2000-03-23 | Inst Pflanzengenetik & Kultur | Differenzierte Herzzellen mit pathologischen Merkmalen als in vitro-Modell für Herzerkrankungen |
| IL159895A0 (en) * | 2001-07-20 | 2004-06-20 | Technion Res & Dev Foundation | Methods of generating human cardiac cells and tissues and uses thereof |
| EP1497410A4 (en) * | 2002-04-01 | 2005-05-25 | Peter K Law | CELL TRANSPLANTATION FOR CARDIAC REGENERATION |
-
2003
- 2003-07-25 EP EP03771801A patent/EP1551991A4/en not_active Withdrawn
- 2003-07-25 CA CA2493588A patent/CA2493588C/en not_active Expired - Lifetime
- 2003-07-25 NZ NZ537245A patent/NZ537245A/en not_active IP Right Cessation
- 2003-07-25 MX MXPA05000283A patent/MXPA05000283A/es unknown
- 2003-07-25 JP JP2004524781A patent/JP2005533518A/ja active Pending
- 2003-07-25 US US10/627,245 patent/US7611852B2/en not_active Expired - Lifetime
- 2003-07-25 AU AU2003252155A patent/AU2003252155B2/en not_active Expired
- 2003-07-25 KR KR1020057001457A patent/KR20050026008A/ko not_active Ceased
- 2003-07-25 WO PCT/US2003/023174 patent/WO2004011603A2/en not_active Ceased
- 2003-07-25 BR BR0312764-8A patent/BR0312764A/pt not_active Application Discontinuation
- 2003-07-25 CN CNA038179032A patent/CN1671860A/zh active Pending
-
2004
- 2004-12-22 IL IL16594304A patent/IL165943A0/xx active IP Right Grant
-
2005
- 2005-01-25 IS IS7663A patent/IS7663A/is unknown
- 2005-02-25 NO NO20051030A patent/NO20051030L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1671860A (zh) | 2005-09-21 |
| CA2493588C (en) | 2012-09-11 |
| US20040106095A1 (en) | 2004-06-03 |
| AU2003252155B2 (en) | 2009-01-22 |
| US7611852B2 (en) | 2009-11-03 |
| CA2493588A1 (en) | 2004-02-05 |
| AU2003252155A1 (en) | 2004-02-16 |
| JP2005533518A (ja) | 2005-11-10 |
| EP1551991A2 (en) | 2005-07-13 |
| MXPA05000283A (es) | 2005-03-31 |
| WO2004011603A2 (en) | 2004-02-05 |
| EP1551991A4 (en) | 2006-09-20 |
| NO20051030L (no) | 2005-04-07 |
| BR0312764A (pt) | 2005-07-26 |
| WO2004011603A3 (en) | 2004-07-08 |
| NZ537245A (en) | 2010-04-30 |
| KR20050026008A (ko) | 2005-03-14 |
| IL165943A0 (en) | 2006-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7663A (is) | Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum | |
| DK2298237T3 (da) | Hjerteprotese | |
| EP1702247A4 (en) | HEART VALVE REPOSITIONABLE | |
| EP1530449A4 (en) | Artificial cornea | |
| PL377590A1 (pl) | Nowe zastosowanie erytropoetyny w chorobach serca | |
| CL2003002417A1 (es) | Tratamiento de tejido con celulas mesenquimales indifereenciadas | |
| DE60316652D1 (de) | Endoskop | |
| DE60312054D1 (de) | Prothese | |
| DE60324178D1 (de) | THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN | |
| DE60304102D1 (de) | Hautreinigungszusammensetzung | |
| DE60311298D1 (de) | Kopfhautbehandlung | |
| AU2003241291A8 (en) | Vascularized human skin equivalent | |
| DK1576091T3 (da) | Human adult olefaktorisk stamcelle | |
| DE60325967D1 (de) | Stimulierung von hämatopoiese bei ex vivo aktivierten immunzellen | |
| EP1708757A4 (en) | USE OF PLURIPOTENTIAL CELLS TAKEN FROM HUMAN CORDIAL BLOOD BLOOD FOR THE TREATMENT OF DISEASE | |
| EP1551225A4 (en) | KRYOKONSERVATION OF HAPEN-MODIFIED TUMOR CELLS | |
| ATE389742T1 (de) | Gewebebehandlungsmittel | |
| DE602004015552D1 (de) | Körperfettmessgerät | |
| EP1500694A4 (en) | LUBRICANT COMPOSITION | |
| DE50211671D1 (de) | Implantierbare Prothese | |
| DE60318635D1 (de) | Herzstimulationsvorrichtung | |
| DE60312992D1 (de) | Medizinisches implantat | |
| DE112004002142D2 (de) | Hautcreme | |
| DE50301087D1 (de) | Herzhalter | |
| AU2003286808A8 (en) | Dopamine neurons from human embryonic stem cells |